
Auditor29 Oct 2026, 02:10 pm
Senores Pharmaceuticals Appoints Joint Statutory Auditor
AI Summary
Senores Pharmaceuticals Limited announced that its Board of Directors has approved the appointment of M/s Talati and Talati LLP as Joint Statutory Auditors. They will serve alongside the existing auditors, M/s. Pankaj R. Shah and Associates, for the period from 2026-27 to 2030-31. This decision was made based on the recommendation of the Audit Committee. The board meeting also reviewed the un-audited financial results for the quarter and half-year ended September 30, 2026, with M/s. Pankaj R. Shah and Associates issuing their Limited Review Reports.
Key Highlights
- Joint Statutory Auditors appointed for a five-year term.
- Appointment aims to strengthen audit oversight and compliance.
- Board also reviewed Q2 FY27 unaudited financial results.
- Existing auditors M/s. Pankaj R. Shah and Associates will continue.
- Appointment effective from the 2026-27 financial year.
Price Impact
More from SENORES